FDA Receive Reports Linking Heparin to Possible Deaths

In Cardio
Thu, 10 Apr 2008

It was these problems that prompted Baxter International to recall most of its heparin products in February 2008. Baxter spokeswoman Erin Gardiner reiterated that the company believes four deaths may be linked to its version of heparin. APP Pharmaceuticals spokeswoman Maili Bergman said none of the 62 cases cited by the FDA were associated with its brand of the blood thinner.

«« Researchers Identify Heparin Chemical Contaminant

Certain Arthritis Drugs May Protect the Heart »»

Latest Articles

Decision-Making in the ICU
- Journal Article
- 19/04/2024
Decision-making in the ICU is a multifaceted process that involves clinical assessment, collaboration among multidisciplinary teams, ethical considerations, evidence-based practice, communication, and continuous adaptation to evolving clinical scenarios. Balancing the complex factors requires
READ MORE
Dealing With Uncertainty in ICU Decision-Making: A Practical Guide
- Journal Article
- 19/04/2024
When the stakes are high, and the path ahead is uncertain, the decisions made, especially if a patient continues to worsen, can be sources of self-torment and can haunt us for a long time. Our goal is to suggest ways to steer decision-making for intensivists in the face of uncertainty by prop
READ MORE
The Least Bad Decision: Crisis Standards of Care After the Pandemic
- Journal Article
- 19/04/2024
COVID-19 was an emergency that lasted for years and left few regions of the world untouched. The pandemic shone a spotlight on both the strengths and weaknesses of our disaster planning. What worked, what did not, and how can we better plan for future emergencies? The COVID-19 pandemic fo
READ MORE

It was these problems that prompted Baxter International to recall most of its heparin products in February 2008. Baxter spokeswoman Erin Gardiner reiter...